The natural course of progressive systemic sclerosis patients with interstitial lung involvement
✍ Scribed by Musellim Benan; Ikitimur Hande; Ongen Gul
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 153 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0770-3198
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
D-penicillamine has been used to treat systemic sclerosis (scleroderma) for nearly two decades. Improvement in cutaneous fibrosis in patients treated with this drug has been documented in a number of uncontrolled studies (1). The effect of D-penicillamine on established visceral involvement due to s
## Abstract ## Objective To evaluate the prognostic value of bronchoalveolar lavage (BAL) cellular profiles in patients with systemic sclerosis–associated interstitial lung disease (SSc‐ILD). ## Methods BAL cellularity was examined in relation to mortality (n = 141), serial pulmonary function fi